Contractors for the Centers for Medicare and Medicaid Services (CMS) limited access to crucial tests for transplant patients against the recommendations of expert physicians, according to a report by the Health Equity in Transplantation Coalition (HEiTC). The cuts reduce access to non-invasive blood tests for detecting early signs of organ rejection, a move which disproportionately impacts Black and Brown transplant recipients. CMS will decide in the coming weeks whether these cutbacks will be permanent.
Investigating fertilized ACL surgery’s impact on return to play in athletes
The Marshall University Joan C. Edwards School of Medicine is conducting a large-scale trial on fertilized anterior cruciate ligament (ACL) reconstruction, a procedure using the
